JenaValve Technology adds nearly $11 million to its Series C round, taking the total to more than $73 million as it pursues the U.S. market with its transcatheter aortic valve implant.
JenaValve Technology yesterday reported adding nearly $11 million to a Series C funding round, bring the total raise to $73.4 million.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1ukxppD
Cap comentari:
Publica un comentari a l'entrada